Back to Search
Start Over
Supplementary Figure 1 from Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file, 1635K, Figure S1. MLN8237 dose-escalation and schedule extension schema.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....06cde64f0d7222fa6a3d869e6c18c000